FDA Drug Recalls

Recalls / Class II

Class IID-149-2013

Product

PredniSONE Tablets, USP, 10 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1473-01), b) 1000-count tablets per bottle (NDC 0143-1473-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.

Affected lot / code info
Lot #: 69403A, 69403B, Exp 10/15; 69404A, 69405A, 69515A, 69702A, 69702B, 69703A, Exp 11/15; 69767A, 69767B, Exp 12/15

Why it was recalled

Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.

Recalling firm

Firm
West-ward Pharmaceutical Corp.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
465 Industrial Way W, N/A, Eatontown, New Jersey 07724-2209

Distribution

Quantity
128,319 bottles
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2012-12-05
FDA classified
2013-02-05
Posted by FDA
2013-02-13
Terminated
2015-03-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-149-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls